← Leaderboards
Stelios Theoharis Andreadis
State University Of New York At Buffalo
$16,967,670
Attributed
$21,467,450
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,467,450 · 9
By mechanism
R01$21,467,450 · 9
Top collaborators
- Olga Juliana Baker16 shared
- Fraser James Sim5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Rose-Anne Romano$3,511,528
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsDesignIn VivoLaboratoriesMesenchymal Stem CellsTissuesEngineeringIn VitroBlood VesselsResponseSignal TransductionRegenerative MedicineGrowth FactorHydrogelsMolecularBiomedical EngineeringStem CellsPeptidesAnimal ModelMouse ModelBaseInnovationMediatingTissue Engineering
Grant awards (52)
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$731,290
R01 · FY2025 · DE
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$574,654
R01 · FY2025 · NS · contact PI
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$65,403
R01 · FY2025 · NS · contact PI
Investigation of the effects of interleukin-10 shear thinning hydrogel on human oligodendrocyte progenitor cell survival and differentiation following transplantation$40,812
R01 · FY2025 · NS · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$720,418
R01 · FY2024 · DE
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$553,693
R01 · FY2024 · NS · contact PI
Restoring the regenerative capacity of the aged muscle$399,770
R01 · FY2024 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$739,671
R01 · FY2023 · DE
Cell-free vascular grafts: immunological response and vascular regeneration$647,402
R01 · FY2023 · HL · contact PI
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$571,641
R01 · FY2023 · NS · contact PI
Restoring the regenerative capacity of the aged muscle$399,770
R01 · FY2023 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$736,297
R01 · FY2022 · DE
Cell-free vascular grafts: immunological response and vascular regeneration$662,277
R01 · FY2022 · HL · contact PI
Restoring the regenerative capacity of the aged muscle$399,770
R01 · FY2022 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$761,695
R01 · FY2021 · DE
Cell-free vascular grafts: immunological response and vascular regeneration$558,471
R01 · FY2021 · HL · contact PI
Restoring the regenerative capacity of the aged muscle$399,770
R01 · FY2021 · AG · contact PI
Cell-free vascular grafts: immunological response and vascular regeneration$573,346
R01 · FY2020 · HL · contact PI
Restoring the regenerative capacity of the aged muscle$440,770
R01 · FY2020 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$394,480
R01 · FY2020 · DE
Direct reprogramming of epidermal cells to neural crest derivatives for cell therapies$416,490
R01 · FY2019 · EB · contact PI
High throughput genetic and functional screens for restoring stem cell potential$397,174
R01 · FY2019 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$389,471
R01 · FY2019 · DE
Direct reprogramming of epidermal cells to neural crest derivatives for cell therapies$416,490
R01 · FY2018 · EB · contact PI
High throughput genetic and functional screens for restoring stem cell potential$397,174
R01 · FY2018 · AG · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$389,471
R01 · FY2018 · DE
Direct reprogramming of epidermal cells to neural crest derivatives for cell therapies$416,490
R01 · FY2017 · EB · contact PI
High throughput genetic and functional screens for restoring stem cell potential$411,724
R01 · FY2017 · AG · contact PI
Reversing the effects of donor aging on adult stem cell potential$391,481
R01 · FY2017 · HL · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$388,366
R01 · FY2017 · DE
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$91,583
R01 · FY2017 · DE
Direct reprogramming of epidermal cells to neural crest derivatives for cell therapies$463,328
R01 · FY2016 · EB · contact PI
Reversing the effects of donor aging on adult stem cell potential$392,146
R01 · FY2016 · HL · contact PI
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION$374,822
R01 · FY2016 · DE
Reversing the effects of donor aging on adult stem cell potential$386,165
R01 · FY2015 · HL · contact PI
The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland$329,218
R01 · FY2015 · DE
Reversing the effects of donor aging on adult stem cell potential$381,251
R01 · FY2014 · HL · contact PI
The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland$342,815
R01 · FY2014 · DE
The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland$53,435
R01 · FY2014 · DE
The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland$386,250
R01 · FY2013 · DE
The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland$364,075
R01 · FY2012 · DE
Stem Cells for Vascular Tissue Engineering$387,321
R01 · FY2011 · HL · contact PI
Stem Cells for Vascular Tissue Engineering$387,321
R01 · FY2010 · HL · contact PI
Stem Cells for Vascular Tissue Engineering$387,321
R01 · FY2009 · HL · contact PI
Stem Cells for Vascular Tissue Engineering$372,696
R01 · FY2008 · HL · contact PI
Retroviral Gene Transfer to Epidermal Stem Cells$291,310
R01 · FY2007 · EB · contact PI
Retroviral Gene Transfer to Epidermal Stem Cells$300,009
R01 · FY2006 · EB · contact PI
Retroviral Gene Transfer to Epidermal Stem Cells$307,228
R01 · FY2005 · EB
Regulated Insulin Delivery From Tissue Engineered Skin *$274,750
R01 · FY2005 · DK
Retroviral Gene Transfer to Epidermal Stem Cells$307,228
R01 · FY2004 · EB
Regulated Insulin Delivery From Tissue Engineered Skin *$224,100
R01 · FY2004 · DK
Retroviral Gene Transfer to Epidermal Stem Cells$277,347
R01 · FY2003 · EB